Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
BSND
Introduction
Bartter syndrome, infantile, with sensorineural deafness (Barttin), also known as BSND, is a human gene which is associated with Bartter syndrome.[1]
This gene encodes an essential beta subunit for CLC chloride channels. These heteromeric channels localize to basolateral membranes of renal tubules and of potassium-secreting epithelia of the inner ear. Mutations in this gene have been associated with Bartter syndrome with sensorineural deafness.[1]
References
References
External links
External links
- Human BSND genome location and BSND gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Birkenhäger R, Otto E, Schürmann MJ, et al. (2001). “Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure”. Nat. Genet. 29 (3): 310–4. doi:10.1038/ng752. PMID 11687798.
- Estévez R, Boettger T, Stein V, et al. (2001). “Barttin is a Cl− channel beta-subunit crucial for renal Cl− reabsorption and inner ear K+ secretion”. Nature. 414 (6863): 558–61. doi:10.1038/35107099. PMID 11734858.
- Waldegger S, Jeck N, Barth P, et al. (2003). “Barttin increases surface expression and changes current properties of ClC-K channels”. Pflügers Arch. 444 (3): 411–8. doi:10.1007/s00424-002-0819-8. PMID 12111250.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Miyamura N, Matsumoto K, Taguchi T, et al. (2003). “Atypical Bartter syndrome with sensorineural deafness with G47R mutation of the beta-subunit for ClC-Ka and ClC-Kb chloride channels, barttin”. J. Clin. Endocrinol. Metab. 88 (2): 781–6. doi:10.1210/jc.2002-021398. PMID 12574213.
- Hayama A, Rai T, Sasaki S, Uchida S (2004). “Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene”. Histochem. Cell Biol. 119 (6): 485–93. doi:10.1007/s00418-003-0535-2. PMID 12761627.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Embark HM, Böhmer C, Palmada M, et al. (2005). “Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum- and glucocorticoid-dependent kinases”. Kidney Int. 66 (5): 1918–25. doi:10.1111/j.1523-1755.2004.00966.x. PMID 15496163.
- GarcÃa-Nieto V, Flores C, Luis-Yanes MI, et al. (2006). “Mutation G47R in the BSND gene causes Bartter syndrome with deafness in two Spanish families”. Pediatr. Nephrol. 21 (5): 643–8. doi:10.1007/s00467-006-0062-1. PMID 16572343.
- Ozlu F, YapicioÄŸlu H, Satar M, et al. (2006). “Barttin mutations in antenatal Bartter syndrome with sensorineural deafness”. Pediatr. Nephrol. 21 (7): 1056–7. doi:10.1007/s00467-006-0108-4. PMID 16773427.
- Scholl U, Hebeisen S, Janssen AG, et al. (2006). “Barttin modulates trafficking and function of ClC-K channels”. Proc. Natl. Acad. Sci. U.S.A. 103 (30): 11411–6. doi:10.1073/pnas.0601631103. PMC 1544099. PMID 16849430.